Escitalopram levels in women before and after menopause
Part of Mental health clinical trials.
This study looks at how the body processes escitalopram (an antidepressant) differently in women before and after menopause. It aims to help doctors understand if dosing should be adjusted based on menopausal status.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Women aged 40 to 60
- Diagnosed with depression or generalized anxiety disorder
- Currently taking escitalopram for at least a month
- Either have regular periods (and are in the second half of your cycle) or have not had a period for at least a year
- Not taking certain other medications or hormone treatments (like birth control pills or hormone replacement therapy)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether escitalopram, a common antidepressant, helps people who are experiencing their first episode of depression and have never taken medication for it. It also looks at how the drug works in the brain.
This study compares two ways of taking estrogen during menopause to see which one better supports memory and thinking. You would receive either a steady dose or a pulse dose of estrogen, along with a progestin, and researchers will track your brain health over time.
This study tests whether a genetics-guided approach to choosing and adjusting escitalopram (an anxiety medicine) can improve safety and effectiveness for anxious teens. It also checks that participants have certain anxiety severity scores and can safely take the study medication.
This Phase 4 study tests an “optimized” medication approach for adults with major depressive disorder (unipolar depression) based on how you respond over time. It may help your care team choose treatments more effectively and reduce trial-and-error.
This study tests whether giving patients a genetic test before they start the antidepressant escitalopram can help doctors choose a safer and more effective dose. It is for people with unipolar depression, with or without anxiety, who have not taken this medication before.
This trial tests whether adding a special fish oil supplement (CreNeuroS) to the antidepressant escitalopram helps improve depression symptoms more than escitalopram alone. If you have moderate to severe depression and are starting or recently started escitalopram, this study may help you find a more effective treatment.
Hear when a new Therapeutic Drug Monitoring (TDM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.